Article Versions Notes

Houvenaeghel G, El Hajj H, Barrou J, Cohen M, Raro P, De Troyer J, Gimbergues P, Tunon de Lara C, Ceccato V, Vaini-Cowen V, et al. External Validation of the SERC Trial Population: Comparison with the Multicenter French Cohort, the Swedish and SENOMIC Trial Populations for Breast Cancer Patients with Sentinel Node Micro-Metastasis. Cancers. 2020; 12(10):2924. https://doi.org/10.3390/cancers12102924

Houvenaeghel, Gilles, Houssein El Hajj, Julien Barrou, Monique Cohen, Pédro Raro, Jérémy De Troyer, Pierre Gimbergues, Christine Tunon de Lara, Vivien Ceccato, Véronique Vaini-Cowen, and et al. 2020. "External Validation of the SERC Trial Population: Comparison with the Multicenter French Cohort, the Swedish and SENOMIC Trial Populations for Breast Cancer Patients with Sentinel Node Micro-Metastasis" Cancers 12, no. 10: 2924. https://doi.org/10.3390/cancers12102924

Houvenaeghel, G., El Hajj, H., Barrou, J., Cohen, M., Raro, P., De Troyer, J., Gimbergues, P., Tunon de Lara, C., Ceccato, V., Vaini-Cowen, V., Faure-Virelizier, C., Marchal, F., Gauthier, T., Jouve, E., Theret, P., Regis, C., Desmons, F., Tallet, A., Boher, J.-M., & the SERC Trial Group. (2020). External Validation of the SERC Trial Population: Comparison with the Multicenter French Cohort, the Swedish and SENOMIC Trial Populations for Breast Cancer Patients with Sentinel Node Micro-Metastasis. Cancers, 12(10), 2924. https://doi.org/10.3390/cancers12102924